Ann: Novozymes Collaboration, page-9

At some time , Leaf are going to have to raise more money .

Maybe the sellers are anticipating it will be at a lower price than 15-16.5c .

Regardless , this announcement is further validation of Leaf's chemical processes and Claeris' decision to work with Leaf .

I suspect these enzymes will be feedstock specific optimisations and not deal makers/breakers .

Incremental improvements to efficiency and recovery should add straight on to the bottom line .

The SP should surge well ahead of where it is now when the bankable feasibility studies are completed and possibly published .